Katharine Heeringa (she/her/hers)

Scribe Therapeutics , California, United States

Kate Heeringa has spent the past eighteen years at pharmaceutical and biotech companies developing high-throughput processes to support protein and nucleic acid production and analysis and drug discovery pipelines, with a focus on automated pipelines. She leads the High-throughput Assay Development and Automation group at Scribe Therapeutics in Alameda, CA. Scribe is revolutionizing the development of optimized genetic medicines that have the potential to durably treat disease at scale. Co-founded by Nobel Prize winner Jennifer Doudna and backed by leading life sciences investors, Scribe is engineering the future of genetic medicine.

Disclosure information not submitted.

Presentation(s):

• Empowering the Full Spectrum of Integrated Lab Automation with Green Button Go Orchestrator

  Monday, February 5, 2024
  12:00 PM – 1:00 PM EST